| Patient | Hubert H. Humphrey |
|---|---|
| Date of birth | 1911-05-27 |
| Identifiers | MRN HR-ML022-SYN-TD; SSN (made up) 000-22-8047 |
| Document date | 1977-04-07 |
| Author | Walter Brandvold, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month follow-up after cystectomy; review after a kidney infection. [S]
Mr. Humphrey returns two months after his last visit, six months after his operation and three weeks after the sick visit for a right kidney infection. The culture grew Escherichia coli susceptible to ciprofloxacin; his fever settled within 48 hours, and he finished the 7-day course. The creatinine recheck planned for one week after that visit was not done, because he was travelling for work. He now drinks about 2 liters a day. Since the new convex wafer he has had no leaks, and the skin below the stoma has healed. Over the past month he has felt more tired by late afternoon, without breathlessness, and his appetite is good. He had a renal ultrasound this morning. He walks 30 minutes most days. [S]
| Element | Detail |
|---|---|
| Infection | Escherichia coli pyelonephritis three weeks ago, resolved on ciprofloxacin |
| Stoma | No leaks since the refit two months ago; skin healed |
| Symptoms | Late-afternoon tiredness for a month |
| Imaging | Renal ultrasound this morning |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Late-afternoon tiredness; no fever; weight up |
| Genitourinary | Negative | Clear urine; no flank pain |
| Integumentary | Negative | Peristomal skin comfortable |
| Respiratory | Negative | No breathlessness or cough |
| Psychiatric | Negative | Mood good; PHQ-2 score 1 |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sodium bicarbonate 650 mg oral tablet, one tablet by mouth twice daily, for metabolic acidosis after an ileal conduit | One tablet twice daily | Oral route | 1977-04-07 | active | S |
| Ciprofloxacin 500 mg oral tablet, one tablet by mouth twice daily for 7 days, for acute pyelonephritis | One tablet twice daily for 7 days | Oral route | 1977-03-17 to 1977-03-23 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1977-04-07 | Body height | 180 | cm | S |
| 1977-04-07 | Body weight | 77.6 | kg | S |
| 1977-04-07 | Body mass index (BMI) [Ratio] | 24 | kg/m2 | S |
| 1977-04-07 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1977-04-07 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1977-04-07 | Heart rate | 70 | /min | S |
| 1977-04-07 | Respiratory rate | 14 | /min | S |
| 1977-04-07 | Body temperature | 36.6 | Cel | S |
| 1977-04-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1977-04-07 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1977-04-07 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1977-04-07 | Chloride [Moles/volume] in Serum or Plasma | 110 | mmol/L | 98-107 mmol/L | High | S |
| 1977-04-07 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 20 | mmol/L | 22-29 mmol/L | Low | S |
| 1977-04-07 | Urea nitrogen [Mass/volume] in Serum or Plasma | 16 | mg/dL | 8-23 mg/dL | Normal | S |
| 1977-04-07 | Creatinine [Mass/volume] in Serum or Plasma | 1.15 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1977-04-07 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1972)/1.73 sq M | 71 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1977-04-07 | Hemoglobin [Mass/volume] in Blood | 13.4 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1977-04-07 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S |
Vital signs recorded on 1977-04-07; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Abdomen | Soft; no flank or costovertebral angle tenderness; no hernia |
| Stoma | Pink and moist; peristomal skin healed; convex wafer sealing well |
| Respiratory | Respiratory rate 14; clear |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Urothelial carcinoma of the bladder, multifocal, with carcinoma in situ, pT2a pN0 (0 of 18 nodes), margins negative, treated by radical cystoprostatectomy with an ileal conduit; no evidence of disease; under surveillance; synthetic modern detail linked to his documented bladder cancer | active | confirmed | Z85.51 | S — Synthetic grade, stage, node count, and margins; the bladder growths, the earlier thiotepa and X-ray therapy, the low-grade malignancy, and the radical cystectomy with a small-intestine conduit are documented (D). Z85.51 is used because the tumor has been removed and no further treatment is directed at it. |
| Ileal conduit urostomy, right lower abdomen | active | confirmed | Z93.6 | S — The small-intestine conduit and the stoma to the right of the navel are documented (D); the coding and the stoma findings are synthetic. |
| Acquired absence of the bladder and part of the urethra after radical cystectomy | active | confirmed | Z90.6 | S — Documented operation (D); synthetic coding. |
| Acquired absence of the prostate after cystoprostatectomy | active | confirmed | Z90.79 | S — Documented operation (D); synthetic coding. |
| Personal history of pelvic radiation for bladder tumor, with earlier intravesical thiotepa | active | confirmed | Z92.3 | S — The thiotepa and X-ray therapy are documented (D); the coding and their relevance to the modern episode are synthetic. |
| Hyperchloremic metabolic acidosis from the ileal conduit, mild | active | confirmed | E87.22 | S — Synthetic finding at the six-month visit, a known effect of urine contact with the ileal segment. |
| Acute right pyelonephritis with an ileal conduit (Escherichia coli), with mild acute kidney injury, treated with oral ciprofloxacin and resolved | resolved | confirmed | N10 | S — Synthetic intercurrent infection at an unscheduled visit, a common complication of an ileal conduit; it does not echo a documented illness of his after the operation. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Chemistry with creatinine, chloride, and bicarbonate | Every 3 to 6 months in the first year after diversion, then yearly | Completed today | Creatinine 1.15 mg/dL, eGFR 71; chloride 110 and bicarbonate 20 mmol/L (low): hyperchloremic acidosis; treatment started |
| Laboratory | Creatinine one week after acute kidney injury | One week after the sick visit | Deferred | Not done, a deviation from the plan made at the sick visit; he was travelling. Today's creatinine of 1.15 mg/dL is near the baseline of 1.12, so the kidney injury resolved and no harm resulted. Corrective action: post-illness rechecks are now booked before he leaves the clinic, with a reminder call |
| Laboratory | Hemoglobin | After major surgery until recovered | Completed today | 13.4 g/dL, recovered from 12.6 |
| Laboratory | Vitamin B12 | Yearly from two to three years after an ileal diversion | Up to date | Baseline normal three months ago |
| Imaging | Upper-tract imaging (renal ultrasound or CT urography) | Every 6 months to year 3, then yearly | Completed today | Renal ultrasound: no hydronephrosis on either side; normal kidneys |
| Imaging | CT of the chest, abdomen, and pelvis (with urographic phase) | Every 6 to 12 months for 2 to 3 years after cystectomy, then yearly | Due | At one year after surgery, in six months |
| Examination | Stoma and peristomal skin | Every visit | Completed today | Skin healed; no leaks since the refit two months ago |
| Examination | Parastomal and incisional hernia | Every visit | Completed today | None |
| Survey | Distress and depression screen (PHQ-2) | Every visit | Completed today | PHQ-2 score 1 |
| Laboratory | Routine urine culture of conduit urine | Only for fever, flank pain, or other signs of infection | Not indicated | Bacteria are expected in conduit urine; no symptoms today |
| Laboratory | Urethral wash cytology | Periodically if the urethra is retained and at high risk | Not indicated | Urethral margin negative and no prostatic urethral involvement |
| Self-management | Fluid intake | Every visit | Completed today | About 2 liters a day since the infection |
Goal progress:
Guideline basis: Holzbeierlein J, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024). J Urol 2024;212(1):3-10 (2024); Trautner BW, et al. IDSA 2025 Guideline Update on Complicated Urinary Tract Infections (2025); CMID: Clinical Monitoring Intelligence Database, urologic cancer monograph (2026)
Follow-up: Annual wellness visit in eight weeks. Primary care in three months with chemistry on sodium bicarbonate. Next scheduled visit 1977-06-02: subsequent annual wellness visit. [S]